Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Saul

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Vaccine|August 27, 2013
Epidemiology of Group B Streptococcus in developing countriesAtul Kumar Johri, Hem Lata, Puja Yadav, et al.
Plos One|July 26, 2017
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1Arianna Marini, Omar Rossi, Maria Grazia Aruta, et al.
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
The Journal of Experimental Medicine|April 26, 2006
Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primatesUlrike Wille-Reece, Barbara J Flynn, Karin Loré, et al.
Frontiers in Immunology|May 21, 2021
Antibodies Elicited by the <i>Shigella sonnei</i> GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster ExtensionFrancesca Micoli, Omar Rossi, Valentino Conti, et al.
Vaccines|September 22, 2020
GMMA Is a Versatile Platform to Design Effective Multivalent Combination VaccinesFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Vaccine|April 20, 2005
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaElissa M Malkin, Anna P Durbin, David J Diemert, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparumAnthony W Stowers, Li-how Chen Lh, Yanling Zhang, et al.
Vaccine|March 9, 2005
Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulationsAaron P Miles, Holly A McClellan, Kelly M Rausch, et al.
Vaccine|April 22, 2008
Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of respondersFeng Qian, Kelly M Rausch, Olga Muratova, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Vaccine|August 27, 2013
Epidemiology of Group B Streptococcus in developing countriesAtul Kumar Johri, Hem Lata, Puja Yadav, et al.
Plos One|July 26, 2017
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1Arianna Marini, Omar Rossi, Maria Grazia Aruta, et al.
Vaccine|May 5, 2009
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervalsRuth D Ellis, Gregory E D Mullen, Mark Pierce, et al.
The Journal of Experimental Medicine|April 26, 2006
Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primatesUlrike Wille-Reece, Barbara J Flynn, Karin Loré, et al.
Frontiers in Immunology|May 21, 2021
Antibodies Elicited by the <i>Shigella sonnei</i> GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster ExtensionFrancesca Micoli, Omar Rossi, Valentino Conti, et al.
Vaccines|September 22, 2020
GMMA Is a Versatile Platform to Design Effective Multivalent Combination VaccinesFrancesca Micoli, Renzo Alfini, Roberta Di Benedetto, et al.
Vaccine|April 20, 2005
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malariaElissa M Malkin, Anna P Durbin, David J Diemert, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparumAnthony W Stowers, Li-how Chen Lh, Yanling Zhang, et al.
Vaccine|March 9, 2005
Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulationsAaron P Miles, Holly A McClellan, Kelly M Rausch, et al.
Vaccine|April 22, 2008
Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of respondersFeng Qian, Kelly M Rausch, Olga Muratova, et al.
Pageof 13